Institutional investors purchased a net $2.8 million shares of ZIOP during the quarter ended June 2016, and now own 38.20% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.0 Million shares of ZIOPHARM Oncology Inc